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Abstract 13 
Glucocorticoids are illegally used as growth promoters in cattle and the analytical methods 14 
officially applied most likely underestimate the precise frequency of the abuse. As a side 15 
effect, the administration of glucocorticoids causes fat infiltration, apoptosis and atrophy of 16 
the thymus. However, gross and histological observations carried out previously showed 17 
that the thymus preserves an intrinsic ability to regenerate. The aim of this work was to 18 
study the transcriptional effects of glucocorticoids on genes likely involved in regeneration 19 
of the epithelial cell network in cervical and thoracic thymus of beef cattle treated with 20 
dexamethasone  or prednisolone  in comparison with the control group. Moreover, the ratio 21 
of BAX/BCL2 genes was examined to verify a possible anti-apoptotic activity occurring at 22 
the same time. In cervical thymus, dexamethasone administration  increased the gene 23 
expression of c-Myc (P < 0.01), TCF3 (P < 0.05), TP63 (P < 0.01) and KRT5 (P < 0.01). In 24 
thoracic thymus of dexamethasone-treated cattle the gene expression of TCF3 (P < 0.01), 25 
TP63 (P < 0.01) and KRT5 (P < 0.05) was increased. These results suggested that thymic 26 
regeneration is underway in the dexamethasone-treated animals. However, the BAX/BCL2 27 
ratio was decreased in both cervical and thoracic thymus of dexamethsone-treated cattle 28 
(P < 0.01 and P < 0.05, respectively), showing an anti-apoptotic effect through the 29 
mitochondrial pathway. Conversely, prednisolone administration caused no change in the 30 
expression of all considered genes. These results sustain the hypothesis that regeneration 31 
occurs in the thymus parenchyma 6 days after the dexamethasone treatment was 32 
discontinued. This hypothesis is also supported by the absence of alterations in thymus of 33 
prednisolone-treated beef cattle. Indeed, previous studies showed the inability of 34 
prednisolone to induce macro- and microscopical lesions in the thymus. Therefore, in this 35 
context, it is not surprising that prednisolone induced no alteration of genes involved in 36 
regeneration pathway. 37 
 38 
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1. Introduction 41 
The administration of natural and synthetic hormones as growth promoters in animals is 42 
banned in the European Union (EU) and analytical methods are officially applied by 43 
national surveillance programs to prevent the illegal use of hormones [1]. 44 
Dexamethasone (DEX) is one of the most commonly administered glucocorticoids (GCs), 45 
and induces fat infiltration, increases apoptosis and causes atrophy of the thymus in cattle, 46 
as a side effect [2-4]. Conversely, prednisolone (PRD), another illicitly used GC, seems to 47 
be unable to induce thymus atrophy [5]. However, it is conceivable that the thymus 48 
preserves an intrinsic ability to regenerate after GCs administration, because the bovine 49 
thymic parenchyma and activity could be restored, as previously shown by gross and 50 
histological observations [4]. Nevertheless, the mechanisms controlling thymus 51 
regeneration remain largely unknown. Conversely, no cellular response seems to be 52 
triggered by PRD administration. It was previously shown that some transcription factors 53 
are over-expressed in the thymic stroma of mice [6]. The thymic epithelial cells (TECs) 54 
showed an up-regulation of c-Myc, TCF3 and TP63 genes during DEX- or irradiation-55 
induced atrophy and a down-regulation after regeneration. These transcription factors 56 
were previously shown to regulate differentiation of epithelial stem cells in various tissues 57 
[7-9], suggesting a role in reconstruction/maintenance of the epithelial cell network. 58 
Moreover, it has been demonstrated that DEX- and irradiation-induced damage of the 59 
thymus resulted in proliferation of specific subset of TEC precursors expressing keratin 5 60 
(KRT5) [6]. 61 
Nevertheless, tissue re-growth is not only the result of cell proliferation, but also of 62 
enhanced cell survival by means of the inhibition of apoptosis or a combination of both 63 
mechanisms [10]. Several studies have highlighted that many of the molecular pathways 64 
involved in thymus atrophy rely on the mitochondria-dependent apoptotic pathway, 65 
involving proteins of the BCL2 family [11,12]. The members of BCL2 family are known to 66 
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be key regulatory proteins in apoptotic events, and can promote either cell survival or cell 67 
death. Indeed, the equilibrium between the pro- and anti-apoptotic members or their 68 
relative amount are crucial to sensitise the cells towards either survival or apoptosis. The 69 
anti-apoptotic effect of BCL2 acts by binding and inhibiting pro-apoptotic proteins like BAX. 70 
The latter promotes apoptosis by altering mitochondrial functions and activating the 71 
release of downstream apoptogenic factors [13]. The aim of this work was to study the 72 
biological mechanisms involved in regeneration following GCs treatment.  73 
 Therefore, an increase of transcript abundance of c-Myc, TCF3, TP63, and KRT5 was 74 
hypothesized in the cervical and thoracic thymus during regeneration of the thymus in beef cattle. 75 
Additionally, the BAX and BCL2 expression and their ratio were examined to evaluate a 76 
possible anti-apoptotic activity occurring at the same time. 77 
 78 
 79 
2. Material and methods 80 
2.1. Animals 81 
The experiment was authorized by the Italian Ministry of Health and the Ethics Committee 82 
of the University of Turin. The carcasses of the treated animals were appropriately 83 
destroyed (2003/74/CE–DL 16 March 2006, No. 158). 84 
All groups of experimental animals were kept in separate pens of 10 × 15 m and were fed 85 
a diet consisting of corn silage, corn, hay and a commercial protein supplement; animals 86 
had ad libitum access to water. Eighteen male Charolaise beef cattle of 17 to 22 mo of age 87 
were divided into the following three groups: group A (n = 6) was administered 88 
dexamethasone–21–sodium-phosphate 0.7 mg/d per os for 40 d; group B (n = 6) was 89 
administered PRD 15 mg/d per os for 30 d; group K (n = 6) served as a control. Each 90 
morning, before the distribution of feed, the animals were tied to the feed trough, and two 91 
trained technicians administered orally one capsule containing the compound using a 92 
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drenching gun. The control animals were treated with a placebo.The animals were 93 
slaughtered 6 d after drug withdrawal. The gross and microscopic findings in the thymus of 94 
these animals were previously reported [5]. 95 
 96 
2.2. Samples 97 
Thoracic and cervical thymus samples from each animal were collected and placed in 98 
RNAlater solution (Ambion, Thermo Fisher Scientific, Waltham, MA) to preserve the RNA 99 
integrity for molecular investigation. 100 
 101 
2.3. Total RNA extraction and quantitative PCR 102 
The expression of c-Myc, TCF3, TP63, KRT5, BAX and BCL2 in the thoracic and cervical 103 
thymus was investigated by quantitative PCR (qPCR). For this purpose, fifty milligrams of 104 
thymus were disrupted using a TissueLyser II (Qiagen, Hilden, Germany) with stainless 105 
steel beads in 1 mL of TRIzol (Invitrogen, Thermo Fisher Scientific). Total RNA was 106 
purified from any residual genomic DNA with a DNA-free kit (Ambion). The integrity of the 107 
RNA was confirmed by the Experion Automated Electrophoresis Station (Bio-Rad, 108 
Hercules, CA), and the concentration was measured by a spectrophotometry. cDNA was 109 
synthesised from 1 µg of total RNA using ImProm-II reverse transcriptase (Promega, 110 
Madison, WI) and random primers (Promega). To determine the amount of the specific 111 
target genes, cDNA was subjected to qPCR using the SYBRGreen method and the IQ5 112 
(Bio-Rad) detection system. The primer sequences were designed using Primer Express v 113 
1.5 (Applied Biosystems, Thermo Fisher Scientific) (Table 1). The peptidylprolyl isomerase 114 
A (cyclophilin A, PPIA) gene was used as a housekeeping control gene, as previously 115 
reported [14]. The expression level of each target gene was calculated using the 2−ΔCq 116 
method, where ΔCq = Cqtarget gene − Cqhousekeeping gene [15]. 117 
 118 
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2.4. Statistical analysis 119 
The data were analyzed using GraphPad InStat version 3.00 (GraphPad Inc., San Diego, 120 
CA). The analysis of c-Myc, TCF3, TP63, KRT5, BAX and BCL2 gene expression and the 121 
analysis of the ratio of BAX and BCL2 expression was performed using one-way analysis 122 
of variance (ANOVA), followed by Dunnett’s post hoc-test versus the control group K. If 123 
Bartlett’s test suggested that the difference between the standard deviations of each group 124 
was significant, then the nonparametric Kruskal-Wallis test with Dunn’s post-test versus 125 
the control group was applied. The Grubbs test was used to reveal potential outliers. A P 126 
value of < 0.05 was considered statistically significant. The data are shown as the mean 127 
arbitrary units (2-ΔCq) ± SEM. 128 
 129 
 130 
3. Results 131 
In the cervical thymus, DEX administration (group A) increased c-Myc expression (mean of 132 
mRNA arbitrary units ± SEM: 9.46 × 10-2 ± 1.49 × 10-2) compared with the control group K 133 
(4.70 × 10-2 ± 3.02 × 10-3) (P < 0.01) (Fig. 1a), TCF3 expression (8.74 × 10-3 ± 4.54 × 10-3) 134 
compared with the control group K (8.48 × 10-4 ± 9.88 × 10-5) (P < 0.05) (Fig. 1b), TP63 135 
expression (8.64 × 10-2 ± 2.71 × 10-2) compared with the control group K (1.56 × 10-2 ± 136 
1.85 × 10-3) (P < 0.01) (Fig. 1c) and KRT5 expression (2.31 × 10-1 ± 1.99 × 10-2) compared 137 
with the control group K (3.75 × 10-2 ± 6.20 × 10-3) (P < 0.01) (Fig. 1d). Conversely, DEX 138 
administration decreased BAX expression (1.54 × 10-3 ± 1.17 × 10-4) compared with the 139 
control group K (3.44 × 10-3 ± 2.38 × 10-4) (P < 0.01) (Fig. 2a). No change in BCL2 140 
expression was observed (Fig. 2b). The administration of PRD (group B) caused no 141 
change in the expression of all considered genes (Fig. 1 and 2). 142 
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In the thoracic thymus, DEX administration (group A) increased TCF3 expression (5.68 × 143 
10-3 ± 1.04 × 10-3) compared with the control group K (2.12 × 10-3 ± 2.51 × 10-4) (P < 0.01) 144 
(Fig. 1b), TP63 expression (6.87 × 10-2 ± 8.70 × 10-3) compared with the control group K 145 
(2.95 × 10-2 ± 3.62 × 10-3) (P<0.01) (Fig. 1c) and KRT5 expression (1.79 × 10-2 ± 6.59 × 10-146 
3 compared with the control group K (5.37 × 10-2 ± 1.88 × 10-3) (P < 0.05) (Fig. 1d). No 147 
change in c-Myc (Fig. 1a) or BCL2 expression was observed (Fig. 2b). Conversely, DEX 148 
administration decreased BAX expression (3.20 × 10-3 ± 2.67 × 10-4) compared with the 149 
control group K (4.91 × 10-3 ± 5.35 × 10-4) (P < 0.05) (Fig. 2a). The administration of PRD 150 
(group B) caused no change in the expression of all considered genes (Fig. 1 and 2). 151 
The BAX/BCL2 ratio was statistically different in both cervical and thoracic thymus of 152 
Group A compared to the controls (P < 0.01 and P < 0.05, respectively) (Fig. 2c). 153 
 154 
 155 
4. Discussion 156 
Council Directive 96/22/EC [1], as amended by Directives 2003/74/EC [16] and 157 
2008/97/EC [17], stipulates that all use of steroids, β-agonists or other substances for the 158 
chemical manipulation of animal growth is severely banned in the EU. However, results 159 
from studies conducted by the Italian Health Ministry indicate that these substances are 160 
persistently used, and therefore a permanent commitment by the public veterinary services 161 
for their prevention and control is required. The thymus represents a GCs target tissue, 162 
and in vitro or ex vivo qualitative and semi-quantitative morphological investigations to 163 
identify the cellular effects of GCs were reported [2,4,18]. 164 
Indeed, the thymus weight and volume of beef cattle following long-term administration of 165 
low doses of DEX were significantly reduced compared with the controls [4]. Moreover, 166 
DEX-treated animals showed severe thymus atrophy, characterized by a serious volume 167 
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reduction of the organ, which in some animals almost disappeared and was replaced by 168 
fat tissue. Histologically, the thymic cortex undergoes atrophy, while the medullary 169 
framework was still present though reduced, showing a pronounced rarefaction of 170 
lymphocytes [5]. Conversely, no histological change was observed in the thymus following 171 
long-term treatment with PRD [5]. 172 
However, partial recovery of thymus weight and structure after 25 days followed by 173 
complete recovery after 32 days was observed in veal calves [3] and similar results have 174 
been observed in thymus of beef cattle examined 26 days after the end of treatment [4]. 175 
Thus, it is conceivable that the thymus preserves an intrinsic ability to regenerate, but the 176 
molecular mechanisms controlling the regeneration of the thymus are largely unknown. 177 
Previous work in mice demonstrated that c-Myc, TP63, and TCF3 gene expression was 178 
up-regulated in TECs during peak thymic atrophy and was down-regulated at later time 179 
points when thymuses were undergoing regeneration [6]. These transcription factors were 180 
previously shown to regulate differentiation of epithelial stem cells in various tissues 181 
[7,8,19] suggesting a role in reconstruction/maintenance of the epithelial cell network. 182 
Consistent with these findings, our results showed an up-regulation of the same 183 
transcription factors in thymus of beef cattle experimentally treated with a low doses of 184 
DEX for a long-term. In contrast, the treatment with PRD did not induce any expression 185 
changes in the genes examined in this study. Since the DEX administration induces the 186 
thymus atrophy [4], whereas PRD treatment appears to have no effects on the thymus 187 
tissue [5], the expression of the transcription factors might play a role in regeneration of 188 
the thymic stroma. 189 
Moreover, it has been demonstrated that DEX-induced damage of the thymus resulted in 190 
proliferation of subset of TEC precursors expressing KRT5 [6]. This active expansion could 191 
explain the significantly over-expression of KRT5 observed in the atrophic thymus of DEX-192 
treated beef cattle compared to controls. 193 
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Glucocorticoids influence the growth and differentiation of thymocytes through several 194 
mechanisms including apoptosis [20]. The apoptotic effect of GCs could shift the balance 195 
between expression of pro-survival and pro-apoptotic factors, ultimately leading to cell 196 
death or apoptosis [21]. In this study, DEX administration caused a decrease of BAX 197 
expression, whereas BCL2 expression remain unchanged. Moreover, the ratio of BAX and 198 
BCL2 expression diminished. These results suggest that an anti-apoptotic effect is 199 
occurring through the mitochondrial pathway, and this may support the hypothesis that 200 
regeneration activity occurs in the thymus parenchyma 6 days after the treatment is 201 
discontinued. 202 
Thus, our data suggested that the observed recovery of thymus of DEX-treated beef cattle 203 
might be mediated by several events, including the elevated expression of transcription 204 
factors involved in differentiation of epithelial stem cells, active proliferation of TECs subset 205 
and inhibition of apoptosis. The expression of this panel of genes appears characteristic of 206 
the animals treated with DEX and not of PRD-treated animals. Indeed, previous studies 207 
showed the inability of PRD to induce macro- and microscopical lesions (i.e. atrophy) in 208 
thymus. Therefore, it is not surprising that PRD does not induce alteration of genes 209 
involved in regeneration pathway. 210 
 211 
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Table 1 Primer sequences used for qPCR. 307 
Gene Sense Sequences 5’  3’ Amplicon 
size (bp) 
GeneBank 
accession 
number 
c-Myc Forward ATGCCACGTGTCTACCCATCA 100 NM_001046074 
 Reverse GACCCTGCCACTGTCCAACT   
TCF3 Forward TGGCTGAGTGCACCCTGAA 107 XM_002691408 
 Reverse CCGGGCCAATTCGTAGTACTT   
TP63 Forward TTCCGTGAGCCAGCTTATCA 100 NM_001191337 
 Reverse GTGGGTGCCCATCATAGGAAT   
KRT5 Forward GAGCCTTTGTTAGAGCAGTACATCAA 100 NM_001008663 
 Reverse CCTGCATATTCCTGAGCTCTGA   
BAX Forward AAGCGCATCGGAGATGAATT 100 NM_173894 
 Reverse CCGCCACTCGGAAAAAGAC   
BCL2 Forward TGGTGGGCGCTTGCAT 100 NM_001166486 
 Reverse TTCTGCTGCTTCTTGAATCTTCTG   
PPIA Forward GCCCCAACACAAATGGTT 95 NM_178320 
 Reverse CCCTCTTTCACCTTGCCAAAG   
308 
 16 
Figure captions 309 
Fig. 1. Effects of dexamethasone-21-sodium phosphate (DEX; group A) or prednisolone 310 
(PRD; group B) on c-Myc (a), TCF3 (b), TP63 (c) and KRT5 (d) gene expression 311 
compared with the control group K in the cervical and thoracic thymus of beef cattle. The 312 
results are presented as the means ± SEM. The y-axes show arbitrary units representing 313 
relative mRNA expression levels. *P < 0.05, **P < 0.01 versus the control group K. 314 
 315 
Fig. 2. Effects of dexamethasone-21-sodium phosphate (DEX; group A) or prednisolone 316 
(PRD; group B) on BAX (a) and BCL2 (b) gene expression compared with the control group 317 
K in the cervical and thoracic thymus of beef cattle. The results are presented as the means 318 
± SEM. The y-axes show arbitrary units representing relative mRNA expression levels. 319 
Effects of dexamethasone-21-sodium phosphate (DEX; group A) or prednisolone (PRD; 320 
group B) on ratio of BAX and BCL2 expression (c) in cervical and thoracic thymus of beef 321 
cattle. *P < 0.05, **P < 0.01 versus the control group K. 322 
